WO2023045601A1 - Method for preparing tricine - Google Patents
Method for preparing tricine Download PDFInfo
- Publication number
- WO2023045601A1 WO2023045601A1 PCT/CN2022/111366 CN2022111366W WO2023045601A1 WO 2023045601 A1 WO2023045601 A1 WO 2023045601A1 CN 2022111366 W CN2022111366 W CN 2022111366W WO 2023045601 A1 WO2023045601 A1 WO 2023045601A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- compound
- acid
- preparation
- methylglycine
- hydroxymethyl
- Prior art date
Links
- SEQKRHFRPICQDD-UHFFFAOYSA-N N-tris(hydroxymethyl)methylglycine Chemical compound OCC(CO)(CO)[NH2+]CC([O-])=O SEQKRHFRPICQDD-UHFFFAOYSA-N 0.000 title claims abstract description 70
- 238000000034 method Methods 0.000 title abstract description 8
- UZMAPBJVXOGOFT-UHFFFAOYSA-N Syringetin Natural products COC1=C(O)C(OC)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 UZMAPBJVXOGOFT-UHFFFAOYSA-N 0.000 title abstract description 6
- 239000007997 Tricine buffer Substances 0.000 title abstract description 6
- KCFYHBSOLOXZIF-UHFFFAOYSA-N dihydrochrysin Natural products COC1=C(O)C(OC)=CC(C2OC3=CC(O)=CC(O)=C3C(=O)C2)=C1 KCFYHBSOLOXZIF-UHFFFAOYSA-N 0.000 title abstract description 6
- 238000002360 preparation method Methods 0.000 claims abstract description 95
- 238000006243 chemical reaction Methods 0.000 claims abstract description 63
- 229940126062 Compound A Drugs 0.000 claims abstract description 43
- NLDMNSXOCDLTTB-UHFFFAOYSA-N Heterophylliin A Natural products O1C2COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC2C(OC(=O)C=2C=C(O)C(O)=C(O)C=2)C(O)C1OC(=O)C1=CC(O)=C(O)C(O)=C1 NLDMNSXOCDLTTB-UHFFFAOYSA-N 0.000 claims abstract description 43
- 150000001875 compounds Chemical class 0.000 claims abstract description 25
- 239000012043 crude product Substances 0.000 claims abstract description 13
- 238000007254 oxidation reaction Methods 0.000 claims abstract description 10
- 238000006460 hydrolysis reaction Methods 0.000 claims abstract description 7
- LOTVQXNRIAEYCG-UHFFFAOYSA-N 3-hydroxy-2-(hydroxymethyl)-2-[hydroxymethyl(methyl)amino]propanoic acid Chemical compound OCN(C)C(CO)(CO)C(O)=O LOTVQXNRIAEYCG-UHFFFAOYSA-N 0.000 claims description 57
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 48
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 38
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 27
- DRSHXJFUUPIBHX-UHFFFAOYSA-N COc1ccc(cc1)N1N=CC2C=NC(Nc3cc(OC)c(OC)c(OCCCN4CCN(C)CC4)c3)=NC12 Chemical compound COc1ccc(cc1)N1N=CC2C=NC(Nc3cc(OC)c(OC)c(OCCCN4CCN(C)CC4)c3)=NC12 DRSHXJFUUPIBHX-UHFFFAOYSA-N 0.000 claims description 27
- 239000002904 solvent Substances 0.000 claims description 25
- 239000007810 chemical reaction solvent Substances 0.000 claims description 20
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 18
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 18
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 18
- 150000002148 esters Chemical class 0.000 claims description 17
- 230000035484 reaction time Effects 0.000 claims description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 15
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 14
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 12
- 238000000746 purification Methods 0.000 claims description 12
- 150000003839 salts Chemical class 0.000 claims description 12
- -1 ammonium cations Chemical class 0.000 claims description 10
- JDNTWHVOXJZDSN-UHFFFAOYSA-N iodoacetic acid Chemical compound OC(=O)CI JDNTWHVOXJZDSN-UHFFFAOYSA-N 0.000 claims description 10
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 claims description 10
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 8
- WBJINCZRORDGAQ-UHFFFAOYSA-N ethyl formate Chemical compound CCOC=O WBJINCZRORDGAQ-UHFFFAOYSA-N 0.000 claims description 8
- 150000008064 anhydrides Chemical class 0.000 claims description 7
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims description 6
- OIFBSDVPJOWBCH-UHFFFAOYSA-N Diethyl carbonate Chemical compound CCOC(=O)OCC OIFBSDVPJOWBCH-UHFFFAOYSA-N 0.000 claims description 6
- 239000003153 chemical reaction reagent Substances 0.000 claims description 6
- FOCAUTSVDIKZOP-UHFFFAOYSA-N chloroacetic acid Chemical compound OC(=O)CCl FOCAUTSVDIKZOP-UHFFFAOYSA-N 0.000 claims description 6
- 229940106681 chloroacetic acid Drugs 0.000 claims description 6
- IEJIGPNLZYLLBP-UHFFFAOYSA-N dimethyl carbonate Chemical compound COC(=O)OC IEJIGPNLZYLLBP-UHFFFAOYSA-N 0.000 claims description 6
- 239000007789 gas Substances 0.000 claims description 6
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 6
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 5
- 239000002253 acid Substances 0.000 claims description 5
- 150000008065 acid anhydrides Chemical class 0.000 claims description 5
- 230000003647 oxidation Effects 0.000 claims description 5
- LULAYUGMBFYYEX-UHFFFAOYSA-N 3-chlorobenzoic acid Chemical compound OC(=O)C1=CC=CC(Cl)=C1 LULAYUGMBFYYEX-UHFFFAOYSA-N 0.000 claims description 4
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 claims description 4
- QBWCMBCROVPCKQ-UHFFFAOYSA-N chlorous acid Chemical compound OCl=O QBWCMBCROVPCKQ-UHFFFAOYSA-N 0.000 claims description 4
- 229910052731 fluorine Inorganic materials 0.000 claims description 4
- 239000011737 fluorine Substances 0.000 claims description 4
- 229910052736 halogen Inorganic materials 0.000 claims description 4
- 150000002367 halogens Chemical class 0.000 claims description 4
- LELOWRISYMNNSU-UHFFFAOYSA-N hydrogen cyanide Chemical compound N#C LELOWRISYMNNSU-UHFFFAOYSA-N 0.000 claims description 4
- NUJOXMJBOLGQSY-UHFFFAOYSA-N manganese dioxide Chemical compound O=[Mn]=O NUJOXMJBOLGQSY-UHFFFAOYSA-N 0.000 claims description 4
- 229910052751 metal Inorganic materials 0.000 claims description 4
- 239000002184 metal Substances 0.000 claims description 4
- AKEJUJNQAAGONA-UHFFFAOYSA-N sulfur trioxide Chemical compound O=S(=O)=O AKEJUJNQAAGONA-UHFFFAOYSA-N 0.000 claims description 4
- NHQDETIJWKXCTC-UHFFFAOYSA-N 3-chloroperbenzoic acid Chemical compound OOC(=O)C1=CC=CC(Cl)=C1 NHQDETIJWKXCTC-UHFFFAOYSA-N 0.000 claims description 3
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 3
- XFXPMWWXUTWYJX-UHFFFAOYSA-N Cyanide Chemical compound N#[C-] XFXPMWWXUTWYJX-UHFFFAOYSA-N 0.000 claims description 3
- 229930040373 Paraformaldehyde Natural products 0.000 claims description 3
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 3
- 229910052794 bromium Inorganic materials 0.000 claims description 3
- 229910001919 chlorite Inorganic materials 0.000 claims description 3
- 229910052619 chlorite group Inorganic materials 0.000 claims description 3
- 238000002425 crystallisation Methods 0.000 claims description 3
- 230000008025 crystallization Effects 0.000 claims description 3
- 238000001035 drying Methods 0.000 claims description 3
- QWPPOHNGKGFGJK-UHFFFAOYSA-N hypochlorous acid Chemical compound ClO QWPPOHNGKGFGJK-UHFFFAOYSA-N 0.000 claims description 3
- 229920002866 paraformaldehyde Polymers 0.000 claims description 3
- LULAYUGMBFYYEX-UHFFFAOYSA-M 3-chlorobenzoate Chemical compound [O-]C(=O)C1=CC=CC(Cl)=C1 LULAYUGMBFYYEX-UHFFFAOYSA-M 0.000 claims description 2
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 claims description 2
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 claims description 2
- 150000003863 ammonium salts Chemical class 0.000 claims description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 2
- 150000007942 carboxylates Chemical class 0.000 claims description 2
- 150000001768 cations Chemical class 0.000 claims description 2
- SOCTUWSJJQCPFX-UHFFFAOYSA-N dichromate(2-) Chemical compound [O-][Cr](=O)(=O)O[Cr]([O-])(=O)=O SOCTUWSJJQCPFX-UHFFFAOYSA-N 0.000 claims description 2
- CMMUKUYEPRGBFB-UHFFFAOYSA-L dichromic acid Chemical compound O[Cr](=O)(=O)O[Cr](O)(=O)=O CMMUKUYEPRGBFB-UHFFFAOYSA-L 0.000 claims description 2
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 claims description 2
- VFNGKCDDZUSWLR-UHFFFAOYSA-N disulfuric acid Chemical compound OS(=O)(=O)OS(O)(=O)=O VFNGKCDDZUSWLR-UHFFFAOYSA-N 0.000 claims description 2
- 229940075933 dithionate Drugs 0.000 claims description 2
- RMGVZKRVHHSUIM-UHFFFAOYSA-N dithionic acid Chemical compound OS(=O)(=O)S(O)(=O)=O RMGVZKRVHHSUIM-UHFFFAOYSA-N 0.000 claims description 2
- 238000001914 filtration Methods 0.000 claims description 2
- DOUHZFSGSXMPIE-UHFFFAOYSA-N hydroxidooxidosulfur(.) Chemical compound [O]SO DOUHZFSGSXMPIE-UHFFFAOYSA-N 0.000 claims description 2
- 230000003993 interaction Effects 0.000 claims description 2
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 claims description 2
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 claims description 2
- 229910017604 nitric acid Inorganic materials 0.000 claims description 2
- 239000007800 oxidant agent Substances 0.000 claims description 2
- 239000001301 oxygen Substances 0.000 claims description 2
- 229910052760 oxygen Inorganic materials 0.000 claims description 2
- 150000002978 peroxides Chemical class 0.000 claims description 2
- FHHJDRFHHWUPDG-UHFFFAOYSA-L peroxysulfate(2-) Chemical compound [O-]OS([O-])(=O)=O FHHJDRFHHWUPDG-UHFFFAOYSA-L 0.000 claims description 2
- FHHJDRFHHWUPDG-UHFFFAOYSA-N peroxysulfuric acid Chemical compound OOS(O)(=O)=O FHHJDRFHHWUPDG-UHFFFAOYSA-N 0.000 claims description 2
- 238000010926 purge Methods 0.000 claims description 2
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 claims description 2
- 150000003462 sulfoxides Chemical class 0.000 claims description 2
- WQYVRQLZKVEZGA-UHFFFAOYSA-N hypochlorite Chemical compound Cl[O-] WQYVRQLZKVEZGA-UHFFFAOYSA-N 0.000 claims 2
- MGWGWNFMUOTEHG-UHFFFAOYSA-N 4-(3,5-dimethylphenyl)-1,3-thiazol-2-amine Chemical compound CC1=CC(C)=CC(C=2N=C(N)SC=2)=C1 MGWGWNFMUOTEHG-UHFFFAOYSA-N 0.000 claims 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims 1
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 claims 1
- 229940077239 chlorous acid Drugs 0.000 claims 1
- LBSANEJBGMCTBH-UHFFFAOYSA-N manganate Chemical compound [O-][Mn]([O-])(=O)=O LBSANEJBGMCTBH-UHFFFAOYSA-N 0.000 claims 1
- JCXJVPUVTGWSNB-UHFFFAOYSA-N nitrogen dioxide Inorganic materials O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 claims 1
- XCRBXWCUXJNEFX-UHFFFAOYSA-N peroxybenzoic acid Chemical compound OOC(=O)C1=CC=CC=C1 XCRBXWCUXJNEFX-UHFFFAOYSA-N 0.000 claims 1
- 239000000047 product Substances 0.000 abstract description 39
- 239000006177 biological buffer Substances 0.000 abstract description 9
- 239000012535 impurity Substances 0.000 abstract description 6
- 239000002994 raw material Substances 0.000 abstract description 5
- 238000009776 industrial production Methods 0.000 abstract description 2
- HTSGKJQDMSTCGS-UHFFFAOYSA-N 1,4-bis(4-chlorophenyl)-2-(4-methylphenyl)sulfonylbutane-1,4-dione Chemical compound C1=CC(C)=CC=C1S(=O)(=O)C(C(=O)C=1C=CC(Cl)=CC=1)CC(=O)C1=CC=C(Cl)C=C1 HTSGKJQDMSTCGS-UHFFFAOYSA-N 0.000 abstract 2
- 239000000706 filtrate Substances 0.000 description 14
- 238000003756 stirring Methods 0.000 description 14
- 239000002585 base Substances 0.000 description 10
- 238000012512 characterization method Methods 0.000 description 7
- 239000000203 mixture Substances 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 4
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- 239000000460 chlorine Substances 0.000 description 3
- MWUXSHHQAYIFBG-UHFFFAOYSA-N nitrogen oxide Inorganic materials O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 3
- 238000009007 Diagnostic Kit Methods 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- GBHSCKFAHCEEAZ-UHFFFAOYSA-N 2-[hydroxymethyl(methyl)amino]acetic acid Chemical compound OCN(C)CC(O)=O GBHSCKFAHCEEAZ-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 238000007400 DNA extraction Methods 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 238000010802 RNA extraction kit Methods 0.000 description 1
- 108010077895 Sarcosine Proteins 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 238000010306 acid treatment Methods 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- KDPAWGWELVVRCH-UHFFFAOYSA-N bromoacetic acid Chemical class OC(=O)CBr KDPAWGWELVVRCH-UHFFFAOYSA-N 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- VEUUMBGHMNQHGO-UHFFFAOYSA-N ethyl chloroacetate Chemical compound CCOC(=O)CCl VEUUMBGHMNQHGO-UHFFFAOYSA-N 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 239000006174 pH buffer Substances 0.000 description 1
- 239000012286 potassium permanganate Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 1
- 238000013341 scale-up Methods 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- FDRCDNZGSXJAFP-UHFFFAOYSA-M sodium chloroacetate Chemical compound [Na+].[O-]C(=O)CCl FDRCDNZGSXJAFP-UHFFFAOYSA-M 0.000 description 1
- MNWBNISUBARLIT-UHFFFAOYSA-N sodium cyanide Chemical compound [Na+].N#[C-] MNWBNISUBARLIT-UHFFFAOYSA-N 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- SESSOVUNEZQNBV-UHFFFAOYSA-M sodium;2-bromoacetate Chemical compound [Na+].[O-]C(=O)CBr SESSOVUNEZQNBV-UHFFFAOYSA-M 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C227/14—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof
- C07C227/18—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions involving amino or carboxyl groups, e.g. hydrolysis of esters or amides, by formation of halides, salts or esters
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C227/02—Formation of carboxyl groups in compounds containing amino groups, e.g. by oxidation of amino alcohols
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C227/38—Separation; Purification; Stabilisation; Use of additives
- C07C227/40—Separation; Purification
Definitions
- the embodiments of the present application relate to the technical field of biological buffers, for example, to a preparation method of tris(hydroxymethyl)methylglycine.
- Tris(hydroxymethyl)methylglycine referred to as Tricine, CAS: 5704-04-1
- Tricine CAS: 5704-04-1
- the pH buffer range of Tricine is 7.4-8.8, which is mainly used to replace glycine, and is used in combination with SDS (sodium dodecyl sulfate) in small molecule protein electrophoresis; in biochemical research, it is often used in biochemical diagnostic kits, DNA/RNA Extraction kits and PCR diagnostic kits.
- Patent CN112194590A discloses a preparation method of tris(hydroxymethyl)methylglycine, which adopts sodium chloroacetate and trishydroxymethylaminomethane in methanol, controls the pH value to react in the range of 8-10, and then passes through cooling , adding concentrated sulfuric acid, crystallization, drying and other steps to obtain tris(hydroxymethyl)methylglycine.
- the above preparation method has the disadvantages of strict control of reaction conditions, cumbersome preparation process, low product purity and high product impurities. Therefore, it is urgent to provide a method for preparing tris(hydroxymethyl)methylglycine with simple production method and high product purity and high yield.
- the embodiment of the present application provides a preparation method of tris(hydroxymethyl)methylglycine.
- the cost of raw materials used in the preparation method is low, the operation is simple, and the yield of the prepared product is relatively high.
- the tris(hydroxymethyl)methylglycine obtained by the above preparation method is (Hydroxymethyl)methylglycine crude product is purified to obtain high-purity tris(hydroxymethyl)methylglycine, which meets the requirements of the biological buffer field for its purity, impurity content, and cost.
- a preparation method for tris(hydroxymethyl)methylglycine comprising the following preparation steps:
- Preparation step S1 react compound I with compound A to obtain compound II;
- Preparation step S2 subjecting the above-mentioned compound II to at least one of hydrolysis reaction, oxidation reaction, and acid-base treatment reaction to obtain tris(hydroxymethyl)methylglycine;
- the above-mentioned acid-base treatment reaction includes at least one of acid treatment and alkali treatment;
- the compound I is trishydroxymethylaminomethane
- the compound A is or its salt, or its salt, or its salt, At least one of the above, the Y is a halogen, OH, SH, an ester corresponding to OH, or an ester corresponding to SH.
- the compound A is At least one of the above, Y 1 and Y 2 are both halogen, OH, SH, esters corresponding to OH, and esters corresponding to SH;
- the compound A is bromoacetic acid, ester corresponding to bromoacetic acid, acid anhydride corresponding to bromoacetic acid, mixed acid anhydride corresponding to bromoacetic acid, bromoacetic acid salt, iodoacetic acid, ester corresponding to iodoacetic acid, anhydride corresponding to iodoacetic acid, At least one of mixed acid anhydride and iodoacetate corresponding to iodoacetic acid.
- the compound A is at least one of esters corresponding to chloroacetic acid, anhydrides corresponding to chloroacetic acid, and mixed anhydrides corresponding to chloroacetic acid.
- the compound A is at least one of formaldehyde, paraformaldehyde, hydrogen cyanide, and cyanide MCN, and the M is one of metal cations, inorganic ammonium cations, and organic amine cations.
- reaction equation of the preparation step S1 is as shown in the following formula (1):
- the ester mentioned in the compound A is at least one of carboxylate, sulfonate, sulfinate and inorganic acid ester.
- the salt mentioned in the compound A is at least one of metal salt, ammonium salt, and complex salt based on acid-base interaction.
- the oxidizing reagent used for the oxidation reaction of compound II is peroxide, ozone, permanganic acid, permanganate, dichromic acid, dichromate, hypochlorous acid, hypochlorous acid, chlorite, chlorite, fluorine, fluorine-containing gas mixture, chlorine, bromine, iodine, manganese dioxide, nitric acid, m-chlorobenzoic acid, m-chlorobenzoate, sulfuric acid, peroxy Sulfuric acid, peroxymonosulfate, dithionic acid, dithionate, pyrosulfuric acid, pyrosulfate, oxygen, caroic acid, m-chloroperoxybenzoic acid, m-chloroperoxybenzoate, sulfur trioxide, di at least one of nitrogen oxides.
- the molar ratio of compound I to compound A is 1: (0.1-10); in the preparation step S2, the molar ratio of compound II to the oxidizing agent is 1: (0.1-10).
- the reaction temperature is -50°C to 200°C
- the reaction pressure is -0.05MPa to 1MPa
- the reaction time is 0.1h to 72h
- the reaction temperature is -50°C to 200°C
- the reaction pressure is -0.05MPa ⁇ 1MPa
- the reaction time is 0.1h ⁇ 72h.
- reaction solvent A is methanol, ethanol, acetone, tetrahydrofuran, ethyl acetate, dimethyl carbonate, diethyl carbonate, diethyl ether, At least one of acetonitrile, dioxane, N,N-dimethylformamide, water, and dimethyl sulfoxide;
- compound II is reacted in a reaction solvent B, and the reaction solvent B is Methanol, ethanol, acetone, tetrahydrofuran, ethyl acetate, dimethyl carbonate, diethyl carbonate, diethyl ether, acetonitrile, dioxane, N,N-dimethylformamide, water, dimethyl sulfoxide at least one.
- the preparation method of above-mentioned tris (hydroxymethyl) methylglycine also comprises following preparation steps:
- the purification solvent is methanol, ethanol, acetone, tetrahydrofuran, ethyl acetate, dimethyl carbonate, diethyl carbonate, ether, acetonitrile, dioxane, N,N-dimethylformamide, water, dimethyl At least one of the group sulfoxide,
- the raw material cost used in the preparation method in the embodiment of the present application is low, and operation is simple, and the product purity obtained is higher, has not only improved the productive rate of the product and reduced the application cost of the product, and the obtained product conforms to the requirement in the biological buffer field.
- the requirements of purity, impurity content, cost, etc., and the method is suitable for industrial production and is suitable for application in the field of biological buffers.
- the preparation method in the embodiment of the present application reacts compound I with compound A, which is easy to obtain and low in cost, to generate compound II, and then performs reactions such as hydrolysis reaction, oxidation reaction, and acid-base treatment reaction of compound II to obtain tris(methylol) base) methylglycine, which optimizes the preparation process, reduces production costs, and improves yield, which is of great significance.
- the product obtained by the preparation process in the examples of the present application is easy to purify and separate.
- the product reaches the high-purity application standard in the field of biological buffers and meets the requirements for large-scale production. various requirements.
- the entire preparation process in the examples of the present application is simple and easy to control, which is beneficial to scale-up production, shortens the reaction production cycle, and can obtain tris(hydroxymethyl)methylglycine with high purity through conventional recrystallization purification, which can effectively increase the yield of the product.
- gauge pressure refers to the amount by which the total absolute pressure exceeds the surrounding atmospheric pressure or the pressure at a certain point in the liquid that is higher than the atmospheric pressure.
- the yield is the percentage ratio between the actual product quality and the theoretical product quality, and the theoretical product quality is calculated based on the non-excessive raw materials in the reaction equation.
- test method nuclear magnetic analysis test, using the AVANCE 400 mega-NMR spectrometer of Bruker (Bruker); the purity of the product is measured by an acid-base titrator.
- a preparation method for tris(hydroxymethyl)methylglycine comprising the following preparation steps:
- compound A is Y is Cl.
- a preparation method for tris(hydroxymethyl)methylglycine comprising the following preparation steps:
- compound A is Y is OH.
- reaction solvent 20g of compound II and methanol as a reaction solvent to a 1L dry reactor to undergo hydrolysis and acid-base treatment with water.
- the temperature of the reaction oil bath is 94°C, and the reaction pressure is 0.015MPa (gauge pressure).
- the time is 6h.
- a preparation method for tris(hydroxymethyl)methylglycine comprising the following preparation steps:
- compound A is Y is Br.
- reaction solvent 20g of compound II and acetonitrile as a reaction solvent to a 1L dry reactor, add water, and undergo a hydrolysis reaction with water.
- the temperature of the reaction oil bath is 90°C, and the reaction pressure is 0.02MPa (gauge pressure). for 6h, and then acid-base treatment reaction.
- a preparation method for tris(hydroxymethyl)methylglycine comprising the following preparation steps:
- compound A is Both Y 1 and Y 2 are Cl.
- reaction time is 6h.
- the tris(hydroxymethyl)methylglycine obtained in the preparation step S2 is dissolved in the mixture of purification solvent ethanol and water, then recrystallized, and then crystallized under low temperature conditions , filtered, and dried to obtain the refined tris(hydroxymethyl)methylglycine boutique, with a purity of 99.5%.
- a preparation method for tris(hydroxymethyl)methylglycine comprising the following preparation steps:
- compound A is sodium bromoacetate.
- the tris(hydroxymethyl)methylglycine obtained in the preparation step S2 is dissolved in a mixture of purification solvent methanol and water, and then recrystallized, and then crystallized under low temperature conditions , filtered, and dried to obtain the refined tris(hydroxymethyl)methylglycine boutique, with a purity of 99.6%.
- a preparation method for tris(hydroxymethyl)methylglycine comprising the following preparation steps:
- compound A is the corresponding ethyl ester of chloroacetic acid.
- reaction oil bath temperature is 65°C
- reaction pressure is 0MPa (gauge pressure)
- reaction time is 6h.
- a preparation method for tris(hydroxymethyl)methylglycine comprising the following preparation steps:
- compound A is the mixture of paraformaldehyde and cyanide NaCN.
- reaction time 6h.
- the tris(hydroxymethyl)methylglycine prepared in the examples has high purity and less impurity content, the crude product yield can reach more than 94%, and the refined product purity reaches more than 99.5%, which can meet Application requirements for biological buffers.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
The present application relates to the technical field of biological buffers, and discloses a method for preparing tricine. The method comprises the following preparation steps: reacting compound I with compound A to obtain compound II; carrying out at least one of a hydrolysis reaction, an oxidation reaction and an acid-base treatment reaction on compound II to obtain a tricine crude product; and purifying same to obtain a tricine refined product. The preparation method of the present application is low in cost of used raw materials, easy in operation and high in purity of the obtained product, and also increases the yield of the product and reduces the application cost of the product. The obtained product meets the requirements of the field of biological buffers regarding the purity, impurity content, cost, etc. thereof. Moreover, the method is suitable for industrial production, and is also suitable for application in the field of biological buffers.
Description
本申请实施例涉及生物缓冲剂技术领域,例如涉及一种三(羟甲基)甲基甘氨酸的制备方法。The embodiments of the present application relate to the technical field of biological buffers, for example, to a preparation method of tris(hydroxymethyl)methylglycine.
三(羟甲基)甲基甘氨酸,简称Tricine,CAS:5704-04-1,是一种应用于生物化学和分子生物学中的两性离子缓冲剂。Tricine的pH缓冲范围为7.4-8.8,主要用来取代甘氨酸,与SDS(十二烷基硫酸钠)配合应用于小分子蛋白电泳中;在生化研究中,常用于生化诊断试剂盒、DNA/RNA提取试剂盒及PCR诊断试剂盒里。Tris(hydroxymethyl)methylglycine, referred to as Tricine, CAS: 5704-04-1, is a zwitterionic buffer used in biochemistry and molecular biology. The pH buffer range of Tricine is 7.4-8.8, which is mainly used to replace glycine, and is used in combination with SDS (sodium dodecyl sulfate) in small molecule protein electrophoresis; in biochemical research, it is often used in biochemical diagnostic kits, DNA/RNA Extraction kits and PCR diagnostic kits.
专利CN112194590A公开了一种三(羟甲基)甲基甘氨酸的制备方法,其采用氯乙酸钠和三羟甲基氨基甲烷在甲醇中,控制pH值在8-10范围内反应,然后再经过冷却、加浓硫酸、结晶、烘干等步骤,得到三(羟甲基)甲基甘氨酸。上述的制备方法存在反应条件控制严格、制备工艺繁琐、产品纯度低、产品杂质高等缺点。因此,亟需提供一种生产方法简单,产品纯度高、收率高的三(羟甲基)甲基甘氨酸的制备方法。Patent CN112194590A discloses a preparation method of tris(hydroxymethyl)methylglycine, which adopts sodium chloroacetate and trishydroxymethylaminomethane in methanol, controls the pH value to react in the range of 8-10, and then passes through cooling , adding concentrated sulfuric acid, crystallization, drying and other steps to obtain tris(hydroxymethyl)methylglycine. The above preparation method has the disadvantages of strict control of reaction conditions, cumbersome preparation process, low product purity and high product impurities. Therefore, it is urgent to provide a method for preparing tris(hydroxymethyl)methylglycine with simple production method and high product purity and high yield.
发明内容Contents of the invention
以下是对本文详细描述的主题的概述。本概述并非是为了限制权利要求的保护范围。The following is an overview of the topics described in detail in this article. This summary is not intended to limit the scope of the claims.
本申请实施例提供一种三(羟甲基)甲基甘氨酸的制备方法,该制备方法中使用的原料成本低,操作简单,制备所得的产品的产率较高,上述的制备方法所得的三(羟甲基)甲基甘氨酸粗品经过纯化后,得到纯度较高的三(羟甲基)甲基甘氨酸精品,符合生物缓冲剂领域对其纯度、杂质含量、成本等的要求。The embodiment of the present application provides a preparation method of tris(hydroxymethyl)methylglycine. The cost of raw materials used in the preparation method is low, the operation is simple, and the yield of the prepared product is relatively high. The tris(hydroxymethyl)methylglycine obtained by the above preparation method is (Hydroxymethyl)methylglycine crude product is purified to obtain high-purity tris(hydroxymethyl)methylglycine, which meets the requirements of the biological buffer field for its purity, impurity content, and cost.
本申请实施例采用如下技术方案实现:The embodiment of the present application adopts the following technical solutions to realize:
一种三(羟甲基)甲基甘氨酸的制备方法,包括如下制备步骤:A preparation method for tris(hydroxymethyl)methylglycine, comprising the following preparation steps:
制备步骤S1:将化合物I与化合物A进行反应,得到化合物II;Preparation step S1: react compound I with compound A to obtain compound II;
制备步骤S2:将上述的化合物II进行水解反应、氧化反应、酸碱处理反应 中的至少一种反应,得到三(羟甲基)甲基甘氨酸;Preparation step S2: subjecting the above-mentioned compound II to at least one of hydrolysis reaction, oxidation reaction, and acid-base treatment reaction to obtain tris(hydroxymethyl)methylglycine;
上述的酸碱处理反应包括酸处理、碱处理的至少一种;The above-mentioned acid-base treatment reaction includes at least one of acid treatment and alkali treatment;
其中,所述化合物I为三羟甲基氨基甲烷;Wherein, the compound I is trishydroxymethylaminomethane;
所述化合物A为
或其盐、
或其盐、
或其盐、
中的至少一种,所述Y为卤素、OH、SH、OH对应的酯、SH对应的酯。
The compound A is or its salt, or its salt, or its salt, At least one of the above, the Y is a halogen, OH, SH, an ester corresponding to OH, or an ester corresponding to SH.
优选地,所述化合物A为
中的至少一种,所述Y
1、Y
2均为卤素、OH、SH、OH对应的酯、SH对应的酯;
Preferably, the compound A is At least one of the above, Y 1 and Y 2 are both halogen, OH, SH, esters corresponding to OH, and esters corresponding to SH;
优选地,所述化合物A为溴乙酸、溴乙酸对应的酯、溴乙酸对应的酸酐、溴乙酸对应的混酸酐、溴乙酸盐、碘乙酸、碘乙酸对应的酯、碘乙酸对应的酸酐、碘乙酸对应的混酸酐、碘乙酸盐中的至少一种。Preferably, the compound A is bromoacetic acid, ester corresponding to bromoacetic acid, acid anhydride corresponding to bromoacetic acid, mixed acid anhydride corresponding to bromoacetic acid, bromoacetic acid salt, iodoacetic acid, ester corresponding to iodoacetic acid, anhydride corresponding to iodoacetic acid, At least one of mixed acid anhydride and iodoacetate corresponding to iodoacetic acid.
优选地,所述化合物A为氯乙酸对应的酯、氯乙酸对应的酸酐、氯乙酸对应的混酸酐中的至少一种。Preferably, the compound A is at least one of esters corresponding to chloroacetic acid, anhydrides corresponding to chloroacetic acid, and mixed anhydrides corresponding to chloroacetic acid.
优选地,所述化合物A为甲醛、多聚甲醛、氰氢酸、氰化物MCN中的至少一种,所述M为金属正离子、无机铵正离子、有机胺正离子中的一种。Preferably, the compound A is at least one of formaldehyde, paraformaldehyde, hydrogen cyanide, and cyanide MCN, and the M is one of metal cations, inorganic ammonium cations, and organic amine cations.
该制备步骤S1的反应方程式为如下式(1)所示:The reaction equation of the preparation step S1 is as shown in the following formula (1):
该制备步骤S2的反应方程式为如下式(2)所示:The reaction equation of the preparation step S2 is as shown in the following formula (2):
优选地,所述化合物A中所提到的酯为羧酸酯、磺酸酯、亚磺酸酯、无机酸酯中的至少一种。Preferably, the ester mentioned in the compound A is at least one of carboxylate, sulfonate, sulfinate and inorganic acid ester.
优选地,所述化合物A中所提到的盐为金属盐、铵盐、基于酸碱作用的络合盐中的至少一种。Preferably, the salt mentioned in the compound A is at least one of metal salt, ammonium salt, and complex salt based on acid-base interaction.
优选地,制备步骤S2中,化合物II进行氧化反应时所使用的氧化试剂为过氧化物、臭氧、高锰酸、高锰酸盐、重铬酸、重铬酸盐、次氯酸、次氯酸盐、亚氯酸、亚氯酸盐、氟气、含氟气的混合气、氯气、溴、碘、二氧化锰、硝酸、间氯苯甲酸、间氯苯甲酸盐、硫酸、过一硫酸、过一硫酸盐、连二硫酸、连二硫酸盐、焦硫酸、焦硫酸盐、氧气、卡罗酸、间氯过氧苯甲酸、间氯过氧苯甲酸盐、三氧化硫、二氧化氮中的至少一种。Preferably, in the preparation step S2, the oxidizing reagent used for the oxidation reaction of compound II is peroxide, ozone, permanganic acid, permanganate, dichromic acid, dichromate, hypochlorous acid, hypochlorous acid, chlorite, chlorite, fluorine, fluorine-containing gas mixture, chlorine, bromine, iodine, manganese dioxide, nitric acid, m-chlorobenzoic acid, m-chlorobenzoate, sulfuric acid, peroxy Sulfuric acid, peroxymonosulfate, dithionic acid, dithionate, pyrosulfuric acid, pyrosulfate, oxygen, caroic acid, m-chloroperoxybenzoic acid, m-chloroperoxybenzoate, sulfur trioxide, di at least one of nitrogen oxides.
优选地,制备步骤S1中,化合物I与化合物A的摩尔比为1:(0.1~10);制备步骤S2中,化合物II与氧化试剂的摩尔比为1:(0.1~10)。Preferably, in the preparation step S1, the molar ratio of compound I to compound A is 1: (0.1-10); in the preparation step S2, the molar ratio of compound II to the oxidizing agent is 1: (0.1-10).
优选地,制备步骤S1中,反应温度为-50℃~200℃,反应压力为-0.05MPa~1MPa,反应时间为0.1h~72h;制备步骤S2中,反应温度为-50℃~200℃,反应压力为-0.05MPa~1MPa,反应时间为0.1h~72h。Preferably, in the preparation step S1, the reaction temperature is -50°C to 200°C, the reaction pressure is -0.05MPa to 1MPa, and the reaction time is 0.1h to 72h; in the preparation step S2, the reaction temperature is -50°C to 200°C, The reaction pressure is -0.05MPa~1MPa, and the reaction time is 0.1h~72h.
优选地,制备步骤S1中,化合物I与化合物A在反应溶剂A中反应,所述反应溶剂A为甲醇、乙醇、丙酮、四氢呋喃、乙酸乙酯、碳酸二甲酯、碳酸二乙酯、乙醚、乙腈、二氧六环、N,N-二甲基甲酰胺、水、二甲基亚砜中的至少一种;制备步骤S2中,化合物II在反应溶剂B中反应,所述反应溶剂B为甲醇、乙醇、丙酮、四氢呋喃、乙酸乙酯、碳酸二甲酯、碳酸二乙酯、乙醚、乙腈、二氧六环、N,N-二甲基甲酰胺、水、二甲基亚砜中的至少一种。Preferably, in the preparation step S1, compound I reacts with compound A in a reaction solvent A, the reaction solvent A is methanol, ethanol, acetone, tetrahydrofuran, ethyl acetate, dimethyl carbonate, diethyl carbonate, diethyl ether, At least one of acetonitrile, dioxane, N,N-dimethylformamide, water, and dimethyl sulfoxide; in the preparation step S2, compound II is reacted in a reaction solvent B, and the reaction solvent B is Methanol, ethanol, acetone, tetrahydrofuran, ethyl acetate, dimethyl carbonate, diethyl carbonate, diethyl ether, acetonitrile, dioxane, N,N-dimethylformamide, water, dimethyl sulfoxide at least one.
上述的三(羟甲基)甲基甘氨酸的制备方法还包括如下制备步骤:The preparation method of above-mentioned tris (hydroxymethyl) methylglycine also comprises following preparation steps:
在干燥条件下,使用干燥密闭设备或在干燥气体吹扫下,将制备步骤S2中所得粗品的三(羟甲基)甲基甘氨酸溶于纯化溶剂中,然后进行重结晶,再在低温 条件下进行结晶、过滤、干燥,得到精制的三(羟甲基)甲基甘氨酸。Under dry conditions, use dry airtight equipment or under dry gas purging, dissolve the tris(hydroxymethyl)methylglycine of the crude product obtained in the preparation step S2 in the purification solvent, then recrystallize, and then recrystallize under low temperature conditions Carry out crystallization, filtration and drying to obtain refined tris(hydroxymethyl)methylglycine.
所述纯化溶剂为甲醇、乙醇、丙酮、四氢呋喃、乙酸乙酯、碳酸二甲酯、碳酸二乙酯、乙醚、乙腈、二氧六环、N,N-二甲基甲酰胺、水、二甲基亚砜、中的至少一种。The purification solvent is methanol, ethanol, acetone, tetrahydrofuran, ethyl acetate, dimethyl carbonate, diethyl carbonate, ether, acetonitrile, dioxane, N,N-dimethylformamide, water, dimethyl At least one of the group sulfoxide,
相比相关技术,本申请实施例的有益效果在于:Compared with related technologies, the beneficial effects of the embodiments of the present application are:
本申请实施例中的制备方法中使用的原料成本低,操作简单,获得的产品纯度较高,不仅提高了产品的产率和降低了产品的应用成本,所得的产品符合生物缓冲剂领域对其纯度、杂质含量、成本等的要求,而且该方法适合工业化生产,适合于在生物缓冲剂领域的应用。The raw material cost used in the preparation method in the embodiment of the present application is low, and operation is simple, and the product purity obtained is higher, has not only improved the productive rate of the product and reduced the application cost of the product, and the obtained product conforms to the requirement in the biological buffer field. The requirements of purity, impurity content, cost, etc., and the method is suitable for industrial production and is suitable for application in the field of biological buffers.
本申请实施例中的制备方法通过选用易获得且成本低的化合物I与化合物A反应,生成化合物II,再将化合物II进行水解反应、氧化反应、酸碱处理反应等反应,得到三(羟甲基)甲基甘氨酸,其优化制备工艺,降低生产成本,提高收率,具有重大意义。The preparation method in the embodiment of the present application reacts compound I with compound A, which is easy to obtain and low in cost, to generate compound II, and then performs reactions such as hydrolysis reaction, oxidation reaction, and acid-base treatment reaction of compound II to obtain tris(methylol) base) methylglycine, which optimizes the preparation process, reduces production costs, and improves yield, which is of great significance.
本申请实施例中的制备工艺所得的产品,容易提纯和分离,对于在反应过程中生成的副产物和杂质,使产品达到生物缓冲剂领域对高纯度的应用标准,满足了对大规模生产应用的各方面要求。The product obtained by the preparation process in the examples of the present application is easy to purify and separate. For the by-products and impurities generated in the reaction process, the product reaches the high-purity application standard in the field of biological buffers and meets the requirements for large-scale production. various requirements.
本申请实施例中的整个制备工艺简单、易控制,有利于放大生产,缩短反应生产周期,且经过常规的重结晶纯化即可得到纯度较高的三(羟甲基)甲基甘氨酸,可以有效地提高产品的收率。The entire preparation process in the examples of the present application is simple and easy to control, which is beneficial to scale-up production, shortens the reaction production cycle, and can obtain tris(hydroxymethyl)methylglycine with high purity through conventional recrystallization purification, which can effectively increase the yield of the product.
在阅读并理解了详细描述后,可以明白其他方面。Other aspects will become apparent after reading and understanding the detailed description.
下面,结合具体实施方式,对本申请做进一步描述,需要说明的是,在不相冲突的前提下,以下描述的各实施例之间或各技术特征之间可以任意组合形成新的实施例。需要说明的是,其中实施例中使用的术语是为了描述特定的具体实施方案,不构成对本申请保护范围的限制。另外,本申请使用的原料均为普通市售产品,因此不需要对其来源做具体限定。Hereinafter, the present application will be further described in conjunction with specific implementation methods. It should be noted that, on the premise of not conflicting, the various embodiments or technical features described below can be combined arbitrarily to form new embodiments. It should be noted that the terms used in the examples are for describing specific implementations and do not limit the protection scope of the present application. In addition, the raw materials used in this application are all common commercially available products, so there is no need to specifically limit their sources.
本申请中提到的压力数值,如果无特殊说明,均指表压,表压是指总绝对压力超过周围大气压力之数或液体中某一点高出大气压力的那部分压力。The pressure values mentioned in this application, unless otherwise specified, refer to gauge pressure, and gauge pressure refers to the amount by which the total absolute pressure exceeds the surrounding atmospheric pressure or the pressure at a certain point in the liquid that is higher than the atmospheric pressure.
产率是以实际的产品质量与理论的产品质量的百分比比值,理论的产品质量是以反应方程式中不过量的原料进行计算。The yield is the percentage ratio between the actual product quality and the theoretical product quality, and the theoretical product quality is calculated based on the non-excessive raw materials in the reaction equation.
在以下实施例中,测试方法:核磁分析测试,使用布鲁克(Bruker)公司的AVANCE 400兆核磁共振波谱仪;产品的纯度通过酸碱滴定仪测定。In the following examples, test method: nuclear magnetic analysis test, using the AVANCE 400 mega-NMR spectrometer of Bruker (Bruker); the purity of the product is measured by an acid-base titrator.
实施例1Example 1
一种三(羟甲基)甲基甘氨酸的制备方法,包括如下制备步骤:A preparation method for tris(hydroxymethyl)methylglycine, comprising the following preparation steps:
制备步骤S1:Preparation step S1:
在搅拌条件下,向1L的干燥反应器中加入20g化合物I三羟甲基氨基甲烷、化合物A、反应溶剂乙醇,化合物I、化合物A的摩尔比分别为1:1,反应油浴温度为60℃,反应压力为0MPa(表压),反应时间为4h。Under stirring conditions, add 20g compound I trishydroxymethylaminomethane, compound A, reaction solvent ethanol in the dry reactor of 1L, the molar ratio of compound I, compound A is respectively 1:1, and reaction oil bath temperature is 60 °C, the reaction pressure is 0MPa (gauge pressure), and the reaction time is 4h.
反应完成后降至常温,过滤去不溶物,滤液减压旋转蒸发除去溶剂,浓缩,制备得到化合物II粗品;After the reaction was completed, the temperature was lowered to normal temperature, the insoluble matter was filtered off, the filtrate was evaporated under reduced pressure to remove the solvent, concentrated, and the crude compound II was prepared;
制备步骤S2:Preparation step S2:
在搅拌条件下,向1L的干燥反应器中加入20g化合物II、反应溶剂乙醇,加入氧化试剂过氧化氢,化合物II和氧化试剂的摩尔比分别为1:3,反应油浴温度为65℃,反应压力为0MPa(表压),反应时间为6h。Under stirring conditions, add 20 g of compound II, ethanol as a reaction solvent, and hydrogen peroxide as an oxidation reagent to a 1 L dry reactor. The molar ratio of compound II to the oxidation reagent is 1:3, and the temperature of the reaction oil bath is 65 ° C. The reaction pressure is 0MPa (gauge pressure), and the reaction time is 6h.
反应完成后降至常温,过滤去不溶物,滤液减压旋转蒸发除去溶剂,浓缩,制备得到三(羟甲基)甲基甘氨酸粗品,粗品产率为90%。After the reaction was completed, the temperature was lowered to normal temperature, the insolubles were filtered off, the filtrate was evaporated under reduced pressure to remove the solvent, and concentrated to prepare a crude product of tris(hydroxymethyl)methylglycine with a yield of 90%.
制备步骤S3:Preparation step S3:
在干燥条件下,使用干燥密闭设备,将制备步骤S2中所得粗品的三(羟甲基)甲基甘氨酸溶于纯化溶剂乙醇中,然后进行重结晶,再在低温条件下进行结晶、过滤、干燥,得到精制的三(羟甲基)甲基甘氨酸精品,精品纯度为99.5%。Under dry conditions, use dry airtight equipment to dissolve the tris(hydroxymethyl)methylglycine obtained in the preparation step S2 in the purification solvent ethanol, then recrystallize, and then crystallize, filter, and dry under low temperature conditions , to obtain refined tris(hydroxymethyl)methylglycine fine product, the fine product purity is 99.5%.
该产品的核磁共振表征数据如下:The NMR characterization data of this product are as follows:
1H NMR(400MHz,D
2O)δ3.8ppm(6H),3.7ppm(2H)。
1 H NMR (400 MHz, D 2 O) δ 3.8 ppm (6H), 3.7 ppm (2H).
实施例2Example 2
一种三(羟甲基)甲基甘氨酸的制备方法,包括如下制备步骤:A preparation method for tris(hydroxymethyl)methylglycine, comprising the following preparation steps:
制备步骤S1:Preparation step S1:
在搅拌条件下,向1L的干燥反应器中加入20g化合物I三羟甲基氨基甲烷、化合物A、反应溶剂甲醇,化合物I、化合物A的摩尔比分别为1:1.05,反应油浴温度为60℃,反应压力为0.01MPa(表压),反应时间为4h。Under stirring conditions, add 20g compound I trishydroxymethylaminomethane, compound A, reaction solvent methanol in the dry reactor of 1L, the molar ratio of compound I, compound A is respectively 1:1.05, and reaction oil bath temperature is 60 °C, the reaction pressure is 0.01MPa (gauge pressure), and the reaction time is 4h.
反应完成后降至常温,过滤去不溶物,滤液减压旋转蒸发除去溶剂,浓缩,制备得到化合物II粗品;After the reaction was completed, the temperature was lowered to normal temperature, the insoluble matter was filtered off, the filtrate was evaporated under reduced pressure to remove the solvent, concentrated, and the crude compound II was prepared;
制备步骤S2:Preparation step S2:
在搅拌条件下,向1L的干燥反应器中加入20g化合物II、反应溶剂甲醇,与水发生水解反应以及酸碱处理,反应油浴温度为94℃,反应压力为0.015MPa(表压),反应时间为6h。Under stirring conditions, add 20g of compound II and methanol as a reaction solvent to a 1L dry reactor to undergo hydrolysis and acid-base treatment with water. The temperature of the reaction oil bath is 94°C, and the reaction pressure is 0.015MPa (gauge pressure). The time is 6h.
反应完成后降至常温,过滤去不溶物,滤液减压旋转蒸发除去溶剂,浓缩,制备得到三(羟甲基)甲基甘氨酸粗品,粗品产率为93%。After the reaction was completed, the temperature was lowered to normal temperature, the insoluble matter was filtered off, the filtrate was evaporated under reduced pressure to remove the solvent, and concentrated to prepare a crude product of tris(hydroxymethyl)methylglycine with a yield of 93%.
制备步骤S3:Preparation step S3:
在干燥条件下,使用干燥密闭设备,将制备步骤S2中所得粗品的三(羟甲基)甲基甘氨酸溶于纯化溶剂乙醇中,然后进行重结晶,再在低温条件下进行结晶、过滤、干燥,得到精制的三(羟甲基)甲基甘氨酸精品,精品纯度为99.6%。Under dry conditions, use dry airtight equipment to dissolve the tris(hydroxymethyl)methylglycine obtained in the preparation step S2 in the purification solvent ethanol, then recrystallize, and then crystallize, filter, and dry under low temperature conditions , to obtain refined tris(hydroxymethyl)methylglycine fine product, the fine product purity is 99.6%.
该产品的核磁共振表征数据如下:The NMR characterization data of this product are as follows:
1H NMR(400MHz,D
2O)δ3.8ppm(6H),3.7ppm(2H)。
1 H NMR (400 MHz, D 2 O) δ 3.8 ppm (6H), 3.7 ppm (2H).
实施例3Example 3
一种三(羟甲基)甲基甘氨酸的制备方法,包括如下制备步骤:A preparation method for tris(hydroxymethyl)methylglycine, comprising the following preparation steps:
制备步骤S1:Preparation step S1:
在搅拌条件下,向1L的干燥反应器中加入20g化合物I三羟甲基氨基甲烷、化合物A、反应溶剂乙腈,化合物I、化合物A的摩尔比分别为1:2,反应油浴温度为60℃,反应压力为-0.01MPa(表压),反应时间为4h。Under stirring conditions, add 20g compound I trishydroxymethylaminomethane, compound A, reaction solvent acetonitrile in the dry reactor of 1L, the molar ratio of compound I, compound A is respectively 1:2, and reaction oil bath temperature is 60 °C, the reaction pressure is -0.01MPa (gauge pressure), and the reaction time is 4h.
反应完成后降至常温,过滤去不溶物,滤液减压旋转蒸发除去溶剂,浓缩,制备得到化合物II粗品;After the reaction was completed, the temperature was lowered to normal temperature, the insoluble matter was filtered off, the filtrate was evaporated under reduced pressure to remove the solvent, concentrated, and the crude compound II was prepared;
制备步骤S2:Preparation step S2:
在搅拌条件下,向1L的干燥反应器中加入20g化合物II、反应溶剂乙腈,加入水,与水发生水解反应,反应油浴温度为90℃,反应压力为0.02MPa(表压),反应时间为6h,再进行酸碱处理反应。Under stirring conditions, add 20g of compound II and acetonitrile as a reaction solvent to a 1L dry reactor, add water, and undergo a hydrolysis reaction with water. The temperature of the reaction oil bath is 90°C, and the reaction pressure is 0.02MPa (gauge pressure). for 6h, and then acid-base treatment reaction.
反应完成后降至常温,过滤去不溶物,滤液减压旋转蒸发除去溶剂,浓缩,制备得到三(羟甲基)甲基甘氨酸粗品,粗品产率为94%。After the reaction was completed, the temperature was lowered to normal temperature, the insoluble matter was filtered off, the filtrate was evaporated under reduced pressure to remove the solvent, and concentrated to prepare a crude product of tris(hydroxymethyl)methylglycine with a yield of 94%.
制备步骤S3:Preparation step S3:
在干燥条件下,使用干燥密闭设备,将制备步骤S2中所得粗品的三(羟甲基)甲基甘氨酸溶于纯化溶剂乙腈中,然后进行重结晶,再在低温条件下进行结晶、过滤、干燥,得到精制的三(羟甲基)甲基甘氨酸精品,精品纯度为99.7%。Under dry conditions, using dry airtight equipment, dissolve the tris(hydroxymethyl)methylglycine of the crude product obtained in the preparation step S2 in the purification solvent acetonitrile, then recrystallize, and then crystallize, filter and dry under low temperature conditions , to obtain refined tris(hydroxymethyl)methylglycine fine product, the fine product purity is 99.7%.
该产品的核磁共振表征数据如下:The NMR characterization data of this product are as follows:
1H NMR(400MHz,D
2O)δ3.8ppm(6H),3.7ppm(2H)。
1 H NMR (400 MHz, D 2 O) δ 3.8 ppm (6H), 3.7 ppm (2H).
实施例4Example 4
一种三(羟甲基)甲基甘氨酸的制备方法,包括如下制备步骤:A preparation method for tris(hydroxymethyl)methylglycine, comprising the following preparation steps:
制备步骤S1:Preparation step S1:
在搅拌条件下,向1L的干燥反应器中加入20g化合物I三羟甲基氨基甲烷、化合物A、反应溶剂乙醇和水的混合物,化合物I、化合物A的摩尔比分别为1:4,反应油浴温度为60℃,反应压力为0MPa(表压),反应时间为4h。Under stirring condition, add the mixture of 20g compound I trishydroxymethylaminomethane, compound A, reaction solvent ethanol and water in the dry reactor of 1L, the molar ratio of compound I, compound A is respectively 1:4, reaction oil The bath temperature is 60° C., the reaction pressure is 0 MPa (gauge pressure), and the reaction time is 4 h.
反应完成后降至常温,过滤去不溶物,滤液减压旋转蒸发除去溶剂,浓缩,制备得到化合物II粗品;After the reaction was completed, the temperature was lowered to normal temperature, the insoluble matter was filtered off, the filtrate was evaporated under reduced pressure to remove the solvent, concentrated, and the crude compound II was prepared;
制备步骤S2:Preparation step S2:
在搅拌条件下,向1L的干燥反应器中加入20g化合物II、反应溶剂二氯甲烷,加入氧化试剂高锰酸钾,化合物II和氧化试剂的摩尔比分别为1:3,反应油浴温度为65℃,反应压力为-0.01MPa(表压),反应时间为6h。Under stirring condition, add 20g compound II, reaction solvent dichloromethane in the dry reactor of 1L, add oxidation reagent potassium permanganate, the mol ratio of compound II and oxidation reagent is respectively 1:3, and reaction oil bath temperature is 65°C, the reaction pressure is -0.01MPa (gauge pressure), and the reaction time is 6h.
反应完成后降至常温,过滤去不溶物,滤液减压旋转蒸发除去溶剂,浓缩,制备得到三(羟甲基)甲基甘氨酸粗品,粗品产率为64%。After the reaction was completed, the temperature was lowered to normal temperature, the insoluble matter was filtered off, the filtrate was evaporated under reduced pressure to remove the solvent, and concentrated to prepare a crude product of tris(hydroxymethyl)methylglycine with a yield of 64%.
制备步骤S3:Preparation step S3:
在干燥条件下,使用干燥密闭设备,将制备步骤S2中所得粗品的三(羟甲基)甲基甘氨酸溶于纯化溶剂乙醇和水的混合物中,然后进行重结晶,再在低温条件下进行结晶、过滤、干燥,得到精制的三(羟甲基)甲基甘氨酸精品,精品纯度为99.5%。Under dry conditions, using dry airtight equipment, the tris(hydroxymethyl)methylglycine obtained in the preparation step S2 is dissolved in the mixture of purification solvent ethanol and water, then recrystallized, and then crystallized under low temperature conditions , filtered, and dried to obtain the refined tris(hydroxymethyl)methylglycine boutique, with a purity of 99.5%.
该产品的核磁共振表征数据如下:The NMR characterization data of this product are as follows:
1H NMR(400MHz,D
2O)δ3.8ppm(6H),3.7ppm(2H)。
1 H NMR (400 MHz, D 2 O) δ 3.8 ppm (6H), 3.7 ppm (2H).
实施例5Example 5
一种三(羟甲基)甲基甘氨酸的制备方法,包括如下制备步骤:A preparation method for tris(hydroxymethyl)methylglycine, comprising the following preparation steps:
制备步骤S1:Preparation step S1:
在搅拌条件下,向1L的干燥反应器中加入20g化合物I三羟甲基氨基甲烷、化合物A、反应溶剂甲醇和水的混合物,化合物I、化合物A的摩尔比分别为1:2,反应油浴温度为60℃,反应压力为0MPa(表压),反应时间为4h。Under stirring condition, add the mixture of 20g compound I trishydroxymethylaminomethane, compound A, reaction solvent methanol and water in the dry reactor of 1L, the molar ratio of compound I, compound A is respectively 1:2, reaction oil The bath temperature is 60° C., the reaction pressure is 0 MPa (gauge pressure), and the reaction time is 4 h.
反应完成后降至常温,过滤去不溶物,滤液减压旋转蒸发除去溶剂,浓缩,制备得到化合物II粗品;After the reaction was completed, the temperature was lowered to normal temperature, the insoluble matter was filtered off, the filtrate was evaporated under reduced pressure to remove the solvent, concentrated, and the crude compound II was prepared;
其中,化合物A为溴乙酸钠。Wherein, compound A is sodium bromoacetate.
制备步骤S2:Preparation step S2:
在搅拌条件下,向1L的干燥反应器中加入20g化合物II,经过酸碱处理反应,钠盐变为对应的酸,反应油浴温度为65℃,反应压力为0MPa(表压),反应时间为6h。Under stirring conditions, add 20g of compound II to a 1L dry reactor, after acid-base treatment, the sodium salt becomes the corresponding acid, the temperature of the reaction oil bath is 65°C, the reaction pressure is 0MPa (gauge pressure), and the reaction time for 6h.
反应完成后降至常温,过滤去不溶物,滤液减压旋转蒸发除去溶剂,浓缩,制备得到三(羟甲基)甲基甘氨酸粗品,粗品产率为93%。After the reaction was completed, the temperature was lowered to normal temperature, the insoluble matter was filtered off, the filtrate was evaporated under reduced pressure to remove the solvent, and concentrated to prepare a crude product of tris(hydroxymethyl)methylglycine with a yield of 93%.
制备步骤S3:Preparation step S3:
在干燥条件下,使用干燥密闭设备,将制备步骤S2中所得粗品的三(羟甲基)甲基甘氨酸溶于纯化溶剂甲醇和水的混合物中,然后进行重结晶,再在低温条件下进行结晶、过滤、干燥,得到精制的三(羟甲基)甲基甘氨酸精品,精品纯度为99.6%。Under dry conditions, using a dry airtight device, the tris(hydroxymethyl)methylglycine obtained in the preparation step S2 is dissolved in a mixture of purification solvent methanol and water, and then recrystallized, and then crystallized under low temperature conditions , filtered, and dried to obtain the refined tris(hydroxymethyl)methylglycine boutique, with a purity of 99.6%.
该产品的核磁共振表征数据如下:The NMR characterization data of this product are as follows:
1H NMR(400MHz,D
2O)δ3.8ppm(6H),3.7ppm(2H)。
1 H NMR (400 MHz, D 2 O) δ 3.8 ppm (6H), 3.7 ppm (2H).
实施例6Example 6
一种三(羟甲基)甲基甘氨酸的制备方法,包括如下制备步骤:A preparation method for tris(hydroxymethyl)methylglycine, comprising the following preparation steps:
制备步骤S1:Preparation step S1:
在搅拌条件下,向1L的干燥反应器中加入20g化合物I三羟甲基氨基甲烷、化合物A、反应溶剂甲醇,化合物I、化合物A的摩尔比分别为1:1,反应油浴温度为60℃,反应压力为0MPa(表压),反应时间为4h。Under stirring conditions, add 20g compound I trishydroxymethylaminomethane, compound A, reaction solvent methanol in the dry reactor of 1L, the molar ratio of compound I, compound A is respectively 1:1, and reaction oil bath temperature is 60 °C, the reaction pressure is 0MPa (gauge pressure), and the reaction time is 4h.
反应完成后降至常温,过滤去不溶物,滤液减压旋转蒸发除去溶剂,浓缩,制备得到化合物II粗品;After the reaction was completed, the temperature was lowered to normal temperature, the insoluble matter was filtered off, the filtrate was evaporated under reduced pressure to remove the solvent, concentrated, and the crude compound II was prepared;
其中,化合物A为氯乙酸对应的乙酯。Wherein, compound A is the corresponding ethyl ester of chloroacetic acid.
制备步骤S2:Preparation step S2:
在搅拌条件下,向1L的干燥反应器中加入20g化合物II,经过酸碱处理反应,酯变为对应的酸,反应油浴温度为65℃,反应压力为0MPa(表压),反应时间为6h。Under stirring conditions, add 20g of compound II to a 1L dry reactor. After acid-base treatment, the ester becomes the corresponding acid. The reaction oil bath temperature is 65°C, the reaction pressure is 0MPa (gauge pressure), and the reaction time is 6h.
反应完成后降至常温,过滤去不溶物,滤液减压旋转蒸发除去溶剂,浓缩,制备得到三(羟甲基)甲基甘氨酸粗品,粗品产率为92%。After the reaction was completed, the temperature was lowered to normal temperature, the insolubles were filtered off, the filtrate was evaporated under reduced pressure to remove the solvent, and concentrated to prepare a crude product of tris(hydroxymethyl)methylglycine with a yield of 92%.
制备步骤S3:Preparation step S3:
在干燥条件下,使用干燥密闭设备,将制备步骤S2中所得粗品的三(羟甲基)甲基甘氨酸溶于纯化溶剂乙醇中,然后进行重结晶,再在低温条件下进行结晶、过滤、干燥,得到精制的三(羟甲基)甲基甘氨酸精品,精品纯度为99.5%。Under dry conditions, use dry airtight equipment to dissolve the tris(hydroxymethyl)methylglycine obtained in the preparation step S2 in the purification solvent ethanol, then recrystallize, and then crystallize, filter, and dry under low temperature conditions , to obtain refined tris(hydroxymethyl)methylglycine fine product, the fine product purity is 99.5%.
该产品的核磁共振表征数据如下:The NMR characterization data of this product are as follows:
1H NMR(400MHz,D
2O)δ3.8ppm(6H),3.7ppm(2H)。
1 H NMR (400 MHz, D 2 O) δ 3.8 ppm (6H), 3.7 ppm (2H).
实施例7Example 7
一种三(羟甲基)甲基甘氨酸的制备方法,包括如下制备步骤:A preparation method for tris(hydroxymethyl)methylglycine, comprising the following preparation steps:
制备步骤S1:Preparation step S1:
在搅拌条件下,向1L的干燥反应器中加入20g化合物I三羟甲基氨基甲烷、化合物A、反应溶剂乙醇,化合物I、化合物A的摩尔比分别为1:3,反应油浴温度为60℃,反应压力为0MPa(表压),反应时间为4h。Under stirring conditions, add 20g compound I trishydroxymethylaminomethane, compound A, reaction solvent ethanol in the dry reactor of 1L, the molar ratio of compound I, compound A is respectively 1:3, and reaction oil bath temperature is 60 °C, the reaction pressure is 0MPa (gauge pressure), and the reaction time is 4h.
反应完成后降至常温,过滤去不溶物,滤液减压旋转蒸发除去溶剂,浓缩, 制备得到化合物II粗品;After the reaction was completed, the temperature was lowered to normal temperature, the insoluble matter was filtered off, the filtrate was evaporated under reduced pressure to remove the solvent, concentrated, and the crude compound II was prepared;
其中,化合物A为多聚甲醛和氰化物NaCN的混合物。Among them, compound A is the mixture of paraformaldehyde and cyanide NaCN.
制备步骤S2:Preparation step S2:
在搅拌条件下,向1L的干燥反应器中加入20g化合物II、反应溶剂乙醇,加入水,与水发生水解反应,反应油浴温度为95℃,反应压力为0MPa(表压),反应时间为6h。Under stirring condition, add 20g compound II, reaction solvent ethanol in 1L dry reactor, add water, hydrolysis reaction occurs with water, reaction oil bath temperature is 95 ℃, reaction pressure is 0MPa (gauge pressure), reaction time is 6h.
反应完成后降至常温,过滤去不溶物,滤液减压旋转蒸发除去溶剂,浓缩,制备得到三(羟甲基)甲基甘氨酸粗品,粗品产率为52%。After the reaction was completed, the temperature was lowered to normal temperature, the insoluble matter was filtered off, the filtrate was evaporated under reduced pressure to remove the solvent, and concentrated to prepare a crude product of tris(hydroxymethyl)methylglycine with a yield of 52%.
制备步骤S3:Preparation step S3:
在干燥条件下,使用干燥密闭设备,将制备步骤S2中所得粗品的三(羟甲基)甲基甘氨酸溶于纯化溶剂乙醇中,然后进行重结晶,再在低温条件下进行结晶、过滤、干燥,得到精制的三(羟甲基)甲基甘氨酸精品,精品纯度为99.0%。Under dry conditions, use dry airtight equipment to dissolve the tris(hydroxymethyl)methylglycine obtained in the preparation step S2 in the purification solvent ethanol, then recrystallize, and then crystallize, filter, and dry under low temperature conditions , to obtain refined tris(hydroxymethyl)methylglycine fine product, the fine product purity is 99.0%.
该产品的核磁共振表征数据如下:The NMR characterization data of this product are as follows:
1H NMR(400MHz,D
2O)δ3.8ppm(6H),3.7ppm(2H)。
1 H NMR (400 MHz, D 2 O) δ 3.8 ppm (6H), 3.7 ppm (2H).
通过上述实验可看出,实施例中制备的三(羟甲基)甲基甘氨酸的纯度高、杂质含量少,产物粗品收率最高可达94%以上,产物精品纯度达到99.5%以上,能够满足生物缓冲剂的应用要求。It can be seen from the above experiments that the tris(hydroxymethyl)methylglycine prepared in the examples has high purity and less impurity content, the crude product yield can reach more than 94%, and the refined product purity reaches more than 99.5%, which can meet Application requirements for biological buffers.
上述实施方式仅为本申请的优选实施方式,不能以此来限定本申请保护的范围,本领域的技术人员在本申请的基础上所做的任何非实质性的变化及替换均属于本申请所要求保护的范围。The above-mentioned implementation mode is only the preferred implementation mode of the present application, which cannot limit the protection scope of the present application. Scope of protection claimed.
Claims (11)
- 一种三(羟甲基)甲基甘氨酸的制备方法,其包括如下制备步骤:A preparation method of tris(hydroxymethyl)methylglycine, which comprises the following preparation steps:制备步骤S1:将化合物I与化合物A进行反应,得到化合物II;Preparation step S1: react compound I with compound A to obtain compound II;制备步骤S2:将上述的化合物II进行水解反应、氧化反应、酸碱处理反应中的至少一种反应,得到三(羟甲基)甲基甘氨酸;Preparation step S2: subjecting the above-mentioned compound II to at least one of hydrolysis reaction, oxidation reaction, and acid-base treatment reaction to obtain tris(hydroxymethyl)methylglycine;其中,所述化合物I为三羟甲基氨基甲烷;Wherein, the compound I is trishydroxymethylaminomethane;
- 根据权利要求1所述的三(羟甲基)甲基甘氨酸的制备方法,其中,所述化合物A为 中的至少一种,所述Y 1、Y 2均为卤素、OH、SH、OH对应的酯、SH对应的酯。 The preparation method of tris(hydroxymethyl)methylglycine according to claim 1, wherein, the compound A is At least one of the Y 1 and Y 2 are halogens, OH, SH, esters corresponding to OH, and esters corresponding to SH.
- 根据权利要求1所述的三(羟甲基)甲基甘氨酸的制备方法,其中,所述化合物A为溴乙酸、溴乙酸对应的酯、溴乙酸对应的酸酐、溴乙酸对应的混酸酐、溴乙酸盐、碘乙酸、碘乙酸对应的酯、碘乙酸对应的酸酐、碘乙酸对应的混酸酐、碘乙酸盐中的至少一种。The preparation method of tris(hydroxymethyl)methylglycine according to claim 1, wherein, said compound A is bromoacetic acid, ester corresponding to bromoacetic acid, acid anhydride corresponding to bromoacetic acid, mixed acid anhydride corresponding to bromoacetic acid, bromine At least one of acetate, iodoacetic acid, an ester corresponding to iodoacetic acid, an anhydride corresponding to iodoacetic acid, a mixed anhydride corresponding to iodoacetic acid, and an iodoacetic acid salt.
- 根据权利要求1所述的三(羟甲基)甲基甘氨酸的制备方法,其中,所述化合物A为氯乙酸对应的酯、氯乙酸对应的酸酐、氯乙酸对应的混酸酐中的至少一种。The preparation method of tris(hydroxymethyl)methylglycine according to claim 1, wherein, said compound A is at least one of esters corresponding to chloroacetic acid, anhydrides corresponding to chloroacetic acid, and mixed anhydrides corresponding to chloroacetic acid .
- 根据权利要求1所述的三(羟甲基)甲基甘氨酸的制备方法,其中,所述化合物A为甲醛、多聚甲醛、氰氢酸、氰化物MCN中的至少一种,所述M为金属正离子、无机铵正离子、有机胺正离子中的一种。The preparation method of tris(hydroxymethyl)methylglycine according to claim 1, wherein, said compound A is at least one of formaldehyde, paraformaldehyde, hydrocyanic acid, cyanide MCN, and said M is One of metal cations, inorganic ammonium cations, and organic amine cations.
- 根据权利要求1-4任一项所述的三(羟甲基)甲基甘氨酸的制备方法,其中,所述化合物A中所提到的酯为羧酸酯、磺酸酯、亚磺酸酯、无机酸酯中的至少一种;所述化合物A中所提到的盐为金属盐、铵盐、基于酸碱作用的络合盐中的至少一种。The preparation method of tris(hydroxymethyl)methylglycine according to any one of claims 1-4, wherein, the ester mentioned in the compound A is carboxylate, sulfonate, sulfinate , at least one of inorganic acid esters; the salt mentioned in the compound A is at least one of metal salts, ammonium salts, and complex salts based on acid-base interactions.
- 根据权利要求1所述的三(羟甲基)甲基甘氨酸的制备方法,其中,制备步骤S2中,化合物II进行氧化反应时所使用的氧化试剂为过氧化物、臭氧、高锰酸、高锰酸盐、重铬酸、重铬酸盐、次氯酸、次氯酸盐、亚氯酸、亚氯酸盐、氟气、含氟气的混合气、氯气、溴、碘、二氧化锰、硝酸、间氯苯甲酸、间氯苯甲酸盐、硫酸、过一硫酸、过一硫酸盐、连二硫酸、连二硫酸盐、焦硫酸、焦硫酸盐、氧气、卡罗酸、间氯过氧苯甲酸、间氯过氧苯甲酸盐、三氧化硫、二氧化氮中的至少一种。The preparation method of tris(hydroxymethyl)methylglycine according to claim 1, wherein, in the preparation step S2, the oxidation reagent used when the compound II is oxidized is peroxide, ozone, permanganate, permanganate, Manganate, dichromic acid, dichromate, hypochlorous acid, hypochlorite, chlorous acid, chlorite, fluorine gas, mixed gas containing fluorine gas, chlorine gas, bromine, iodine, manganese dioxide , nitric acid, m-chlorobenzoic acid, m-chlorobenzoate, sulfuric acid, peroxymonosulfuric acid, peroxymonosulfate, dithionic acid, dithionate, pyrosulfuric acid, pyrosulfate, oxygen, caroic acid, m-chloro At least one of peroxybenzoic acid, m-chloroperoxybenzoate, sulfur trioxide, and nitrogen dioxide.
- 根据权利要求1所述的三(羟甲基)甲基甘氨酸的制备方法,其中,制备步骤S1中,化合物I与化合物A的摩尔比为1:(0.1~10);制备步骤S2中,化合物II与氧化试剂的摩尔比为1:(0.1~10)。The preparation method of tris(hydroxymethyl)methylglycine according to claim 1, wherein, in the preparation step S1, the molar ratio of compound I to compound A is 1: (0.1~10); in the preparation step S2, the compound The molar ratio of II to the oxidizing agent is 1: (0.1-10).
- 根据权利要求1所述的三(羟甲基)甲基甘氨酸的制备方法,其中,制备步骤S1中,反应温度为-50℃~200℃,反应压力为-0.05MPa~1MPa,反应时间为0.1h~72h;制备步骤S2中,反应温度为-50℃~200℃,反应压力为-0.05MPa~1MPa,反应时间为0.1h~72h。The preparation method of tris(hydroxymethyl)methylglycine according to claim 1, wherein, in the preparation step S1, the reaction temperature is -50°C to 200°C, the reaction pressure is -0.05MPa to 1MPa, and the reaction time is 0.1 h to 72 hours; in the preparation step S2, the reaction temperature is -50°C to 200°C, the reaction pressure is -0.05MPa to 1MPa, and the reaction time is 0.1h to 72h.
- 根据权利要求1所述的三(羟甲基)甲基甘氨酸的制备方法,其中,制备步骤S1中,化合物I与化合物A在反应溶剂A中反应,所述反应溶剂A为甲醇、乙醇、丙酮、四氢呋喃、乙酸乙酯、碳酸二甲酯、碳酸二乙酯、乙醚、乙腈、二氧六环、N,N-二甲基甲酰胺、水、二甲基亚砜中的至少一种;制备步骤S2中,化合物II在反应溶剂B中反应,所述反应溶剂B为甲醇、乙醇、丙酮、四氢呋喃、乙酸乙酯、碳酸二甲酯、碳酸二乙酯、乙醚、乙腈、二氧六环、N,N-二甲基甲酰胺、水、二甲基亚砜中的至少一种。The preparation method of tris(hydroxymethyl)methylglycine according to claim 1, wherein, in preparation step S1, compound I reacts with compound A in reaction solvent A, and described reaction solvent A is methanol, ethanol, acetone , tetrahydrofuran, ethyl acetate, dimethyl carbonate, diethyl carbonate, ether, acetonitrile, dioxane, N,N-dimethylformamide, water, dimethyl sulfoxide at least one; preparation In step S2, compound II is reacted in a reaction solvent B, and the reaction solvent B is methanol, ethanol, acetone, tetrahydrofuran, ethyl acetate, dimethyl carbonate, diethyl carbonate, ether, acetonitrile, dioxane, At least one of N,N-dimethylformamide, water, and dimethyl sulfoxide.
- 根据权利要求1-10任一项所述的三(羟甲基)甲基甘氨酸的制备方法,其中,还包括如下制备步骤:The preparation method of tris(hydroxymethyl)methylglycine according to any one of claims 1-10, wherein, also comprising the following preparation steps:在干燥条件下,使用干燥密闭设备或在干燥气体吹扫下,将制备步骤S2中所得粗品的三(羟甲基)甲基甘氨酸溶于纯化溶剂中,然后进行重结晶,再在低温条件下进行结晶、过滤、干燥,得到精制的三(羟甲基)甲基甘氨酸;Under dry conditions, use dry airtight equipment or under dry gas purging, dissolve the tris(hydroxymethyl)methylglycine of the crude product obtained in the preparation step S2 in the purification solvent, then recrystallize, and then recrystallize under low temperature conditions Carrying out crystallization, filtering, and drying to obtain refined tris(hydroxymethyl)methylglycine;所述纯化溶剂为甲醇、乙醇、丙酮、四氢呋喃、乙酸乙酯、碳酸二甲酯、碳酸二乙酯、乙醚、乙腈、二氧六环、N,N-二甲基甲酰胺、水、二甲基亚砜中的至少一种。The purification solvent is methanol, ethanol, acetone, tetrahydrofuran, ethyl acetate, dimethyl carbonate, diethyl carbonate, ether, acetonitrile, dioxane, N,N-dimethylformamide, water, dimethyl At least one of the group sulfoxides.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111129423.X | 2021-09-26 | ||
CN202111129423.XA CN113861053B (en) | 2021-09-26 | 2021-09-26 | Preparation method of tris (hydroxymethyl) methylglycine |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2023045601A1 true WO2023045601A1 (en) | 2023-03-30 |
Family
ID=78994553
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CN2022/111366 WO2023045601A1 (en) | 2021-09-26 | 2022-08-10 | Method for preparing tricine |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN113861053B (en) |
WO (1) | WO2023045601A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113861053B (en) * | 2021-09-26 | 2023-12-05 | 苏州亚科科技股份有限公司 | Preparation method of tris (hydroxymethyl) methylglycine |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SU642299A1 (en) * | 1977-09-26 | 1979-01-15 | Научно-производственное объединение "Биохимреактив" | Method of obtaining tricine |
JP2008066588A (en) * | 2006-09-08 | 2008-03-21 | Fujifilm Corp | Polishing solution |
CN101402576A (en) * | 2008-10-23 | 2009-04-08 | 浙江大学 | Method for producing bi(2-hydroxyethyl)imino-tri(hydroxymethyl)methyl hydride |
CN103880691A (en) * | 2014-04-03 | 2014-06-25 | 重庆紫光国际化工有限责任公司 | Clean and environment-friendly production method of N,N-dialkylglycine |
CN108290849A (en) * | 2015-12-10 | 2018-07-17 | 伯拉考成像股份公司 | Contrast agent |
CN112194590A (en) * | 2020-10-16 | 2021-01-08 | 湖南韵邦生物医药有限公司 | Preparation method of tri (hydroxymethyl) methylglycine |
CN113861053A (en) * | 2021-09-26 | 2021-12-31 | 苏州亚科科技股份有限公司 | Preparation method of tri (hydroxymethyl) methylglycine |
-
2021
- 2021-09-26 CN CN202111129423.XA patent/CN113861053B/en active Active
-
2022
- 2022-08-10 WO PCT/CN2022/111366 patent/WO2023045601A1/en unknown
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SU642299A1 (en) * | 1977-09-26 | 1979-01-15 | Научно-производственное объединение "Биохимреактив" | Method of obtaining tricine |
JP2008066588A (en) * | 2006-09-08 | 2008-03-21 | Fujifilm Corp | Polishing solution |
CN101402576A (en) * | 2008-10-23 | 2009-04-08 | 浙江大学 | Method for producing bi(2-hydroxyethyl)imino-tri(hydroxymethyl)methyl hydride |
CN103880691A (en) * | 2014-04-03 | 2014-06-25 | 重庆紫光国际化工有限责任公司 | Clean and environment-friendly production method of N,N-dialkylglycine |
CN108290849A (en) * | 2015-12-10 | 2018-07-17 | 伯拉考成像股份公司 | Contrast agent |
CN112194590A (en) * | 2020-10-16 | 2021-01-08 | 湖南韵邦生物医药有限公司 | Preparation method of tri (hydroxymethyl) methylglycine |
CN113861053A (en) * | 2021-09-26 | 2021-12-31 | 苏州亚科科技股份有限公司 | Preparation method of tri (hydroxymethyl) methylglycine |
Also Published As
Publication number | Publication date |
---|---|
CN113861053A (en) | 2021-12-31 |
CN113861053B (en) | 2023-12-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR102080198B1 (en) | Method of oxidizing using calcium hypochloride and manufacturing for sulfone or sulfide | |
JP6995892B2 (en) | Manufacturing method of Sugamadex | |
WO2023045601A1 (en) | Method for preparing tricine | |
JP6839243B2 (en) | Bis- (4-haloethylbenzenesulfonyl) imide or a salt thereof, a method for producing the same, and a method for producing bis- (4-styrenesulfonyl) imide or a salt thereof using bis- (4-haloethylbenzenesulfonyl) imide as a precursor. | |
CN111909088B (en) | Method for preparing isoquinoline hydrochloride intermediate and Rho kinase inhibitor by using BTC/Ph3PO chloro-system | |
KR101595747B1 (en) | Method for preparing of nafamostat mesilate | |
WO2023142797A1 (en) | Preparation process for sulfonic acid-containing compound | |
CN111909060B (en) | Preparation process of N- (2-acetamido) -2-aminoethanesulfonic acid | |
CN115850082A (en) | Preparation method of 2-nitro-4-trifluoromethylbenzoic acid | |
JP4796776B2 (en) | Method for producing 4,4'-dicarboxy-2,2'-bipyridine | |
CN111269195B (en) | Synthesis method for preparing saccharin | |
JP2018008918A (en) | Method for producing azo compounds | |
US4196132A (en) | Continuous flow process for the preparation of o-chloranil from tetrachlorocatechol | |
JP5637710B2 (en) | {2-Amino-1,4-dihydro-6-methyl-4- (3-nitrophenyl) -3,5-pyridinedicarboxylic acid 3- (1-diphenylmethylazetidin-3-yl) ester 5-isopropyl ester } Manufacturing method | |
JP4747660B2 (en) | Method for producing dithiosulfate compound | |
CN116102531B (en) | Preparation method of salicyl fluorone | |
JPH06340610A (en) | Production of sulfoterephthalic acid | |
CN104829514B (en) | A kind of synthetic method of pharmaceutical intermediate | |
CN115057768A (en) | Synthetic method of 3, 5-dichloro-4-methoxybenzoic acid | |
JP2019043849A (en) | Manufacturing method of perfluoroalkanesulfonyl imidic acid metal salt | |
CN117658837A (en) | Preparation process of 5-aminolevulinic acid and salt thereof | |
CN105037411B (en) | A kind of new pyridoxine derivative and preparation method thereof | |
CN116102531A (en) | Preparation method of salicyl fluorone | |
CN118026832A (en) | Method for preparing halogenated anthraquinone compounds in one step | |
CN115850156A (en) | Method for purifying difluoride compound |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 22871659 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |